Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients

Front Immunol. 2023 Mar 13:14:1124018. doi: 10.3389/fimmu.2023.1124018. eCollection 2023.

Abstract

Background: The role of allergen sensitization in IL-31 production by T cells and specifically in the clinical context of atopic dermatitis (AD) has not been characterized.

Methods: The response to house dust mite (HDM) in purified memory T cells cocultured with epidermal cells from AD patients (n=58) and control subjects (n=11) was evaluated. AD-associated cytokines from culture supernatants, plasma proteins and mRNA expression from cutaneous lesions were assessed and related with the clinical features of the patients.

Results: HDM-induced IL-31 production by memory T cells defined two subsets of AD patients according to the presence or absence of IL-31 response. Patients in the IL-31 producing group showed a more inflammatory profile, and increased HDM-specific (sp) and total IgE levels compared to the IL-31 non-producing group. A correlation between IL-31 production and patient's pruritus intensity, plasma CCL27 and periostin was detected. When the same patients were analyzed based on sp IgE and total IgE levels, an increased IL-31 in vitro response, as well as type 2 markers in plasma and cutaneous lesions, was found in patients with sp IgE levels > 100 kUA/L and total IgE levels > 1000 kU/L. The IL-31 response by memory T cells was restricted to the cutaneous lymphocyte-associated antigen (CLA)+ T-cell subset.

Conclusion: IgE sensitization to HDM allows stratifying IL-31 production by memory T cells in AD patients and relating it to particular clinical phenotypes of the disease.

Keywords: CCL27; CLA+ memory T cells; IL-31; IgE; atopic dermatitis; house dust mite; periostin; pruritus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allergens
  • Animals
  • Cytokines
  • Dermatitis, Atopic*
  • Immunoglobulin E
  • Memory T Cells
  • Pyroglyphidae

Substances

  • Allergens
  • Cytokines
  • Immunoglobulin E

Grants and funding

The study was funded by FIS/ISCIII 2021 (Ministerio de Economía y Competitividad e Instituto de Salud Carlos III; PI21/01179 and PI21/00335) and Fondo Europeo de Desarrollo Regional (FEDER). Additionally, Sans-de San Nicolàs L was granted by a PhD fellowship from the Agency for Management of University and Research Grants of the Generalitat de Catalunya (FI-SDUR 2020); García-Jiménez I was granted by a PhD fellowship from the Universitat de Barcelona (PREDOCS-UB 2020).